Form D Explorer

Form C-AR — Vast Therapeutics, Inc.

0001665160-25-000948 · filed 2025-05-01

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: Vast Therapeutics, Inc.
CIK: 2041605
Entity: Corporation
Jurisdiction: DE
Address: 615 Davis Dr. Suite 800
Morrisville, NC 27560
Phone: —

Most recent fiscal year financials

Total assets

$41,634,211

Cash

—

Short-term debt

—

Long-term debt

$12,899,653

Revenues

$227,645

COGS

—

Taxes paid

—

Net income

$-6,110,183

View original on SEC EDGAR.